ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0399 • ACR Convergence 2020

    A Heavy Burden of Calcinosis Reflects Cumulative Disease Damage in Scleroderma

    Carrie Richardson1, Jamie Perin2, Scott Zeger3, Fredrick Wigley4, Laura Hummers5, Livia Casciola-Rosen6, Antony Rosen7 and Ami Shah8, 1Rush University Medical Center, Chicago, IL, 2JHUSPH, Baltimore, 3Johns Hopkins University, Baltimore, 4Johns Hopkins University School of Medicine, Baltimore, MD, 5Johns Hopkins Univerisity, Ellicott City, MD, 6Johns Hopkins University, Johns Hopkins University, MD, 7Johns Hopkins University, Baltimore, MD, 8Johns Hopkins University School of Medicine, Ellicott City, MD

    Background/Purpose: Ectopic calcification, or calcinosis, is a common complication of scleroderma. However, a subset of scleroderma patients has a heavy burden of calcinosis, which may…
  • Abstract Number: 0400 • ACR Convergence 2020

    Outcomes of Systemic Sclerosis Hospitalizations by Hospital Teaching Status: Analysis of the National Inpatient Sample

    Ehizogie Edigin1, Precious Eseaton2 and Pius Ojemolon3, 1John H Stroger Jr. Hospital of Cook County, Chicago, IL, 2University of Benin Teaching Hospital, Benin, 3St. George's University, St. George's, Grenada

    Background/Purpose: Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease that results in hospitalizations in different hospital settings. It is unclear if outcomes of…
  • Abstract Number: 0401 • ACR Convergence 2020

    Prevalence and Characteristics of Systemic Sclerosis Patients Fulfilling the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus

    Ronald Bass1, Duncan Moore2 and Virginia Steen2, 1Georgetown University School of Medicine, Washington, DC, 2Division of Rheumatology, Department of Medicine, MedStar Georgetown University Hospital, Washington, DC

    Background/Purpose: Literature describing the overlap syndrome of SSc and SLE is limited and has employed a range of case definitions. Our study sought to use…
  • Abstract Number: 0402 • ACR Convergence 2020

    Optical Coherence Tomography of the Skin Detects Scleroderma Changes in Clinically Unaffected Skin: An Opportunity for Early Detection of Systemic Sclerosis

    Giuseppina Abignano1, Duygu Temiz Karadag2, Ozcan Gundogdu3, Giovanni Lettieri4, Maria Carmela Padula5, Angela A Padula5, Paul Emery6, Salvatore D'Angelo5 and Francesco Del Galdo6, 1Rheumatology Institute of Lucania (IReL), Rheumatology Department of Lucania, San Carlo Hospital, Potenza, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK, Potenza, Italy, 2Rheumatology Institute of Lucania (IReL), Rheumatology Department of Lucania, San Carlo Hospital, Potenza, Italy and Department of Rheumatology, Kocaeli University, Kocaeli, Turkey, Kocaeli, Turkey, 3Department of Biomedical Engineering, Kocaeli University, Kocaeli,Turkey, Kocaeli, Turkey, 4Radiology Department, San Carlo Hospital, Potenza, Italy, Potenza, Italy, 5Rheumatology Institute of Lucania (IReL), Rheumatology Department of Lucania, San Carlo Hospital, Potenza, Italy, Potenza, Italy, 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds, United Kingdom

    Background/Purpose: The Very Early Diagnosis Of Systemic Sclerosis (VEDOSS) study has shown that more than 80% of patients with Raynaud’s Phenomenon, specific ANA positivity and…
  • Abstract Number: 0403 • ACR Convergence 2020

    Comparison of Immediate Post-Operative and Long-Term Outcomes in Aortitis and Non-Inflammatory Thoracic Aortic Aneurysms Undergoing Open Surgical Repair

    Adam Mayer1, Alexandra Sperry2, Laarni Quimson3 and Rennie Rhee4, 1University of Pennsylvania, Internal Medicine/Pediatrics Residency Program, Philadelphia, PA, 2Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 3Division of Rheumatology at the University of Chicago, Chicago, IL, 4University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Around 2-12% of patients who undergo open thoracic aortic aneurysm repair are incidentally found to have aortitis on pathology.  There is no standardized approach…
  • Abstract Number: 0404 • ACR Convergence 2020

    Isolated Aortitis: Single Centre Experience of Clinical Spectrum and Management

    Nadia Ahmad1, Ayna Verdiyeva2, Raashid Luqmani2 and Shirish Dubey2, 1Oxford University Hospitals NHS Foundation Trust, Reading, United Kingdom, 2Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

    Background/Purpose: Aortitis was previously regarded as a rare form of large vessel vasculitis (LVV), but is now increasingly being recognised. It may occur in the…
  • Abstract Number: 0405 • ACR Convergence 2020

    Disease Activity and Quality-of-Life Outcomes in Patients with Behçet’s Syndrome Who Achieved and Maintained Oral Ulcer Complete Response with Apremilast Treatment

    Gülen Hatemi1, Alfred Mahr2, Mitsuhiro Takeno3, Doyoung Kim4, Melike Melikoğlu1, Sue Cheng5, Sven Richter5, Michele Brunori6, Maria Paris5, Mindy Chen5 and Yusuf Yazici7, 1Istanbul University‒Cerrahpaşa, Cerrahpaşa Medical School and Behçet’s Disease Research Center, Istanbul, Turkey, 2Cantonal Hospital St. Gallen, St. Gallen, Switzerland, 3Nippon Medical School, Graduate School of Medicine, Tokyo, Japan, 4Yonsei University College of Medicine and Severance Hospital, Seoul, Republic of Korea, 5Amgen Inc., Thousand Oaks, 6Amgen Europe GmbH, Rotkreuz, Switzerland, 7New York University School of Medicine, New York

    Background/Purpose: Recurrent, painful oral ulcers (OU) are common symptoms of Behçet’s syndrome that can impact daily activities and impair quality of life (QoL) (Kokturk A.…
  • Abstract Number: 0406 • ACR Convergence 2020

    Infliximab in Refractory Uveitis Due to Behçet’s Disease: Long Term Follow-up and Therapy Optimization. Multicenter Study of 103 Caucasian Patients

    José Luis Martín-Varillas1, Belén Atienza-Mateo2, Vanesa Calvo-Río3, Emma Beltran-Catalan4, Alfredo Adan5, Marisa Hernandez Garfella6, Elia Valls-Pascual7, Agustín Sellas-Fernández8, N Ortego9, Alejandro Fonollosa10, Olga Maiz Alonso11, Ignacio Torre12, Cruz Fernández-Espartero13, Vega Jovani14, Diana Peiteado15, David Díaz Valle16, Susana Romero-Yuste17, Elena Aurrecoechea1, Miriam García-Arias18, Miguel Ángel Caracuel19, Santos Insúa20, Senén González-Suárez21, Amalia Sánchez Andrade22, Luis Francisco Linares23, Alfredo J García González24, Raquel Almodovar25, Carmen Carrasco Cubero26, María Alcalde Villar27, C Fernandez-Carballido28, Fred A Pages29, Eva Peña Sainz-Pardo24, Rosalia Demetrio-Pablo3, Santos Castañeda30, Miguel Ángel González-Gay31, José Luis Hernández3 and Ricardo Blanco3, 1Hospital Sierrallana, Torrelavega, Spain, 2Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic bone diseases of the musculoskeletal system, IDIVAL; and Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Hospital Universitario Marques de Valdecilla, Santander, Spain, 4Del Mar University Hospital, Barcelona, 5Hospital Clinic, Barcelona, Catalonia, Spain, 6H. Valencia, Valencia, Spain, 7H. Doctor Peset, Valencia, Spain, 8H. Vall d'Hebron, Barcelona, Spain, 9H. San Cecilio, Granada, Spain, 10H. de Cruces, Bilbao, Spain, 11Hospital Universitario Donostia, San Sebastian, Pais Vasco, Spain, 12Hospital Basurto, Bilbao, Spain, 13H. Mostoles, Madrid, Spain, 14H. Alicante, Alicante, Spain, 15Hospital La Paz - IdiPAZ, Madrid, Spain, 16H. Clínico San Carlos, Madrid, Spain, 17H Pontevedra, Coruna, Spain, 18H. La Princesa, Madrid, 19H.U. Reina Sofía, Córdoba, Spain, 20H. Santiago de Compostela, Santiago de Compostela, Spain, 21H. Cabueñes, Gijón, Spain, 22H. Lucus Augusti, Lugo, Spain, 23Hospital de la Arrixaca, Murcia, 24H. 12 de Octubre, Madrid, Spain, 25Fundación Alcorcón University Hospital, Madrid, 26H. Mérida, Mérida, Spain, 27H. Severo Ochoa, Madrid, Spain, 28H San Juan, Alicante, Spain, 29H. Palencia, Palencia, Spain, 30Princesa University Hospital, Universidad Autónoma, Madrid, Madrid, Spain, 31Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

    Background/Purpose: Biologic therapy has improved prognosis of Behçet Disease (BD) uveitis. Although infliximab (IFX) is approved in Japan, most data in Caucasian patients comes from…
  • Abstract Number: 0407 • ACR Convergence 2020

    Achievement of Early and Sustained Complete Response of Oral Ulcers with Apremilast Compared with Placebo in Patients with Active Behçet’s Syndrome

    Gülen Hatemi1, Alfred Mahr2, Mitsuhiro Takeno3, Doyoung Kim4, Melike Melikoğlu1, Sue Cheng5, Sven Richter5, Michele Brunori6, Maria Paris5, Mindy Chen5 and Yusuf Yazici7, 1Istanbul University‒Cerrahpaşa, Cerrahpaşa Medical School and Behçet’s Disease Research Center, Istanbul, Turkey, 2Cantonal Hospital St. Gallen, St. Gallen, Switzerland, 3Nippon Medical School, Graduate School of Medicine, Tokyo, Japan, 4Yonsei University College of Medicine and Severance Hospital, Seoul, Republic of Korea, 5Amgen Inc., Thousand Oaks, 6Amgen Europe GmbH, Rotkreuz, Switzerland, 7New York University School of Medicine, New York

    Background/Purpose: Painful and recurring oral ulcers (OU) are a common manifestation of Behçet’s syndrome that can interfere with eating and have a negative impact on…
  • Abstract Number: 0408 • ACR Convergence 2020

    Epidemiology and Treatment of Behçet’s Disease Insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry

    Nevin Hammam1, Jinoos Yazdany2 and Gabriela Schmajuk3, 1UCSF, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3University of California, San Francisco, Atherton, CA

    Background/Purpose: Behçet’s disease (BD), a rare multisystem vasculitis, is prevalent among Middle Eastern populations but remains rare in North America. Data for patients with BD…
  • Abstract Number: 0409 • ACR Convergence 2020

    Clinical Characteristics, Brain MRI Findings, and Diagnostic Approach of the Central Nervous System Vasculitis by Affected Vessel Size

    Takashi Shimoyama1, Ken Uchino2, Leonard Calabrese3 and Rula Hajj-ali3, 1Nippon Medical School, Nippon, Japan, 2Cleveland Clinic, Cleveland, 3Cleveland Clinic, Cleveland, OH

    Background/Purpose: Diagnosis of the central nervous system vasculitis (CNS-V) is made on the basis of image findings or brain biopsy. Recently, two different subtypes of…
  • Abstract Number: 0410 • ACR Convergence 2020

    Exploring Gene Expression Profile of Primary Central Nervous System Vasculitis

    Carlo Salvarani1, Robert Brown2, Jonas Paludo2, Stefania Croci3, Stephen Ansell4, Caterina Giannini2, Joseph Parisi2, Kenneth Warrington2 and Gene Hunder2, 1Azienda USL-IRCCS di Reggio Emilia e Università di Modena e Reggio Emilia, Reggio Emilia, Italy, 2Mayo Clinic, Rochester, MN, 3Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy, 4Mayo Clinic, Rochester

    Background/Purpose: Primary CNS vasculitis (PCNSV) is an uncommon and poorly understood disease that affects the brain and spinal cord. It includes heterogeneous  histopathological patterns,  clinical…
  • Abstract Number: 0411 • ACR Convergence 2020

    Serial Vessel Wall Enhancement Change on High-Resolution MRI Vessel Wall Imaging in Primary Central Nervous System Vasculitis

    Takashi Shimoyama1, Ken Uchino2, Leonard Calabrese2 and Rula Hajj-ali2, 1Nippon Medical School, Nippon, Japan, 2Cleveland Clinic, Cleveland, OH

    Background/Purpose: High-resolution vessel wall imaging (HR-VWI) is emerging as a tool of notable utility in the diagnosis of central nervous system vasculitis (CNS-V). However, little…
  • Abstract Number: 0412 • ACR Convergence 2020

    2019 Novel Coronavirus Disease (COVID-19) in Patients with Large-Vessels Vasculitis: Single-centre Experience in Paris

    Chloé Comarmond1, Mathilde Leclercq1, Gaëlle Leroux2, Cindy Marques2, Alexandre Le Joncour3, Fanny Domont2, Céline Hatte1, Ségolène Toquet1, Perrine Guillaume-Jugnot1, Anne-Claire Desbois1, Mathieu Vautier1, Aude Rigolet1, Yves Allenbach4, Olivier Benveniste5, David Saadoun2 and Patrice Cacoub2, 1Assistance Publique des Hopitaux de Paris, Paris, France, 2AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France, Centre national de références Maladies Autoimmunes et systémiques rares et Maladies Autoinflammatoires rares, Paris, France, 3APHP, paris, France, 4Sorbonne Université, Paris, Ile-de-France, France, 5Sorbonne Université, paris, France

    Background/Purpose: Advanced age and cardiovascular diseases are recognized as major comorbidities associated with severe forms of coronavirus disease 2019 (COVID-19) caused by the severe acute…
  • Abstract Number: 0413 • ACR Convergence 2020

    Coronavirus Infection and Vasculitis: Identifying Associations Mining the Biomedical Literature

    Alicia Rodriguez Pla1 and Rodrigo Cartin-Ceba2, 1Rheumatology. Mayo Clinic Arizona, Scottsdale, 2Pulmonary. Mayo Clinic Arizona, Scottsdale, AZ

    Background/Purpose: Based on recent publications suggesting an association between COVID-19 and vascular inflammation, our aim was to explore new associations between coronavirus infections and vasculitis…
  • « Previous Page
  • 1
  • …
  • 861
  • 862
  • 863
  • 864
  • 865
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology